+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection



Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection



World Journal of Clinical Cases 5(2): 40-45



A 54-year-old black African woman, 22 years human immunodeficiency virus (HIV)-positive, presented with an acute coronary syndrome. She was taking two nucleoside reverse transcriptase inhibitors and two protease inhibitors. Viral load and CD4 count were stable. Angiography revealed a right coronary artery lesion, which was treated with everolimus eluting stent. She also underwent balloon angioplasty to the first diagonal. She re-presented on three different occasions and technically successful coronary intervention was performed. The patient has reported satisfactory compliance with dual anti platelet therapy throughout. She was successfully treated with surgical revascularisation. The patient did not experience any clinical recurrence on follow up. This case demonstrates exceptionally aggressive multifocal and recurrent instent restenosis in a patient treated for HIV infection, raising the possibility of an association with HIV infection or potentially components of retro viral therapy.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059335468

Download citation: RISBibTeXText

PMID: 28255546


Related references

Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. Eurointervention 12(14): 1757-1765, 2017

Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis. Bmc Cardiovascular Disorders 17(1): 190, 2017

Intravascular ultrasound-guided percutaneous coronary intervention in a human immunodeficiency virus-positive patient with cocaine-associated acute myocardial infarction: case report and review. Heart Lung and Circulation 14(3): 197-200, 2005

Percutaneous coronary intervention in HIV infected patients with human immunodeficiency virus admitted with acute coronary syndrome: case-control study. Medicina Clinica 135(15): 691-694, 2010

Routine functional testing after percutaneous coronary intervention: results of the aggressive diagnosis of restenosis in high-risk patients (ADORE II) trial. Acta Cardiologica 62(2): 143-150, 2007

Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus. Catheterization and Cardiovascular Interventions 85(2): 192-198, 2015

Predictive factors of re-restenosis after repeated sirolimus-eluting stent implantation for SES restenosis and clinical outcomes after percutaneous coronary intervention for SES restenosis. Journal of Interventional Cardiology 22(4): 354-361, 2009

Occurrence of a slowly growing pseudoaneurysm and restenosis in coronary artery following primary percutaneous coronary intervention in a patient with acute myocardial infarction. Anadolu Kardiyoloji Dergisi 9(2): 141-142, 2009

Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review. Bmc Cardiovascular Disorders 15: 101, 2015

Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus. American Journal of Cardiology 100(5): 777-780, 2007

Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation 109(22): 2727-2731, 2004

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention. Bmc Cardiovascular Disorders 9: 48, 2009

Effects of AGI-1067 on restenosis rates in patients undergoing percutaneous coronary intervention with stent placement in the Canadian antioxidant restenosis trial. Circulation 104(17 Suppl.): II 544, 2001

Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy. Transplantation 79(11): 1581-1587, 2005

Detection of coronary restenosis by serial Doppler echocardiographic assessment of coronary flow velocity reserve after percutaneous coronary intervention. Journal of the American College of Cardiology 43(5 Suppl. A): 327A, 2004